Clearing Up Online Misinformation About GLP-1 Safety Online myths about GLP-1 drugslike Ozempic face or exaggerated side effect fearsoften stem from unregulated sources selling counterfeit tirzepatide or semaglutide
Weight loss itself, improved blood sugar stability, and enhanced self-efficacy from achieving health goals also contribute to mood improvements, making it difficult to isolate GLP-1's direct neuropsychiatric effect
Dual GLP-1/GIP receptor agonists are currently being explored as an advanced approach to treat diabetes and obesity, aiming to enhance insulin release and reduce the risk of diabetes-related complications even further
The increased efficacy has reduced the gap with the ~25-30% weight loss achieved with bariatric surgery during the first 2 years (912) and has driven additional efforts for a weight management market projected to reach 77 billion by 2030 (Weight Loss Drugs Boost Obesity Market Value | Morgan Stanley)
Journal of Neuro-Oncology
Measurable weight loss usually appears in weeks 24, though some patients see initial changes by day 1014
